Drug Type Virus-like particle vaccine, Prophylactic vaccine, Multivalent vaccine |
Synonyms Human papillomavirus (types 16 and 18) L1 virus-like particle vaccine ( Xiamen Innovax), Recombinant human papillomavirus bivalent (type 16/18) vaccine (Xiamen Innovax), Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine(Escherichia coli) + [5] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (31 Dec 2019), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Human Papillomavirus Infection | Morocco | 13 May 2022 | |
Uterine Cervical Cancer | China | 31 Dec 2019 |
Phase 3 | 1,025 | (1. Cecolin at Month 0 and 6) | hjvsomaxlz(txbwiholww) = bvmabavlui fzjuwjbenv (abbelxwfxm, kwqjoafwyg - cnqqisidqn) View more | - | 30 Jan 2025 | ||
(2. Cecolin at Month 0 and 12) | hjvsomaxlz(txbwiholww) = rsbiatggdl fzjuwjbenv (abbelxwfxm, uzvwkgojnd - enbngvquiu) View more |